CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Nifty to open flat today

DSIJ Intelligence-3 0 668 Article rating: 5.0

In the previous trading sessions, markets celebrated the phase 1 of the trade deal but that did not last long as the markets gave away most of its gains. As we enter the final trading session of the week, the SGX Nifty is trading flat and is likely to be cautious ahead of the weekend.

Wockhardt gets DCGI approval for newly discovered Antibiotics

DSIJ Intelligence 0 1341 Article rating: 3.9

On Thursday Wockhardt announced that the Drug Controller General of India (DCGI) has approved two of its new antibiotics, EMROK (IV) and EMROK-O for acute bacterial skin and skin structure infections, including diabetic foot infections and concurrent bacteraemia, thereby, becoming the first Indian company to achieve approval for newly-discovered antibiotics.

MF QueryBoard

Ninad Ramdasi 0 1023 Article rating: No rating

Readers are requested to send only one query at a time so that more readers get a chance. Have questions relating to any aspect of personal finance. Ask DSIJ at editorial@DSIJ.in and get your queries resolved. 

Fund of Fortnight

Ninad Ramdasi 0 1443 Article rating: No rating

MF Select- This is our mutual fund recommendation. Every fortnight , we recommend one open-ended equity diversified fund that has the best potential of returns for the next one year considering its constituents remain the same. 

Interview

Ninad Ramdasi 0 896 Article rating: No rating

Market fluctuations and near-term negative returns have always remained temporary and as time progresses; they do get adjusted in one’s portfolio returns and builds a good experience.

Heres How To Tackle The Current Market Scenario

Ninad Ramdasi 0 1272 Article rating: No rating

If you are a serious investor and follow an asset allocation method to decide the asset mix for your portfolio, you would typically have equity, debt, and gold in it. While asset allocation helps in diversifying your portfolio, each of these asset classes requires a different investment strategy to stay on course, advises Hemant Rustagi, CEO, Wiseinvest Advisors.

Kerbside

Sagar Bhosale 0 961 Article rating: No rating

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation

Reviews

Sagar Bhosale 0 1128 Article rating: No rating

In this edition, we have reviewed Tata Power Company and BHEL. We suggest our reader-investors to HOLD in Tata Power Company and BHEL

Moat Stocks For All Seasons !

Ninad Ramdasi 0 2148 Article rating: No rating

It is a dream of any value investor to identify stocks that have some sort of moat in it. What is this ‘moat’ and how does one identify stocks with investment moat? Are these so called moat stocks worth considering? Yogesh Supekar explains how best to identify stocks with investment moat while Karan Bhojwani shares a list of stocks with probable investment moat built in it

Analysis

Sagar Bhosale 0 1649 Article rating: No rating

Godawari Power and Ispat Limited has improved its financial and operational performance over a period of time due to higher realisations and improved capacity utilisation of its plants, thus making it a sound choice for investors

NIFTY Index Chart Analysis

Sagar Bhosale 0 903 Article rating: No rating

The Indian stock market has continued to touch new highs since November 28, 2019. As of now, the Nifty has reached new peaks seven times in the last one and a half months. After breaking down from the narrow range flat base, it bounced back with a gap up and continues to rise.

Recommendations from Auto Parts & Equipment & Cigarettes,Tobacco Products Sectors

Sagar Bhosale 0 1127 Article rating: No rating

The scrips in this column have been recommended with a 15-day investment horizon in mind and carry high risk. Therefore, investors are advised to take into account their risk appetite before investing, as fundamentals may or may not back the recommendations.

Flat start likely, stock specific movement to continue

DSIJ Intelligence-3 0 646 Article rating: 5.0

This Thursday morning, the big news is that US President and Chinese Vice-Premier have signed a ‘phase one’ trade deal in Washington. However, the early trend indicates that the Indian markets are not much cheerful about this deal as signing of deal was on expected lines and domestic markets are expected to witness a flat start.

Capacite Infraprojects Ltd bags EPC contract worth Rs 407.16 crore

DSIJ Intelligence 0 1945 Article rating: 5.0

On January 15, 2020 (Wednesday), Capacite lnfraprojects announced that it had received an Engineering, Procurement and Construction (EPC) contract worth Rs 407.16 crore from Integrated Unit (PW) Division for the construction of a multi-story super speciality hospital building at Sir J J Hospital Campus, Byculla (Mumbai).

Sun Pharma enters into agreement with Rockwell Medical

Apurva Joshi 0 1150 Article rating: 5.0

Sun Pharmaceuticals Limited has announced that one of its wholly-owned subsidiaries has entered into an exclusive licensing and supply agreement with Rockwell Medical Inc, to commercialise Rockwell's Triferic, a proprietary iron replacement and haemoglobin maintenance drug, for treating anaemia in hemodialysis patients in India.

Index trend and stocks in action on January 15, 2020

DSIJ Intelligence-3 0 1072 Article rating: 5.0

The best strategy would be running the long positions with a trailing stop-loss of prior day low. In any case, if the Nifty closes below the breakout level of 12,250 then, the short-term weakness is possible. Stocks in news: Pidilite Industries, Lemon Tree, Godawari Power & Ispat, CSB Bank, National Peroxide, Bharti Airtel.

Dull start in offing

DSIJ Intelligence-3 0 434 Article rating: 5.0

For the last four trading sessions, the bulls have been marching higher and scaling to new heights. The phrase ‘market hit a new peak’ has become such a standard remark, that its absence on one day could hit market participants psyche more badly than any real fundamental factor.

IndusInd Bank falls despite stable asset quality

Pratik Shastri 0 941 Article rating: 4.0

The banking industries performance is decided on many factors such as asset quality (NPAs), deposit growth, loan book growth and provisions for probable defaults of the outstanding loan assets. The early trend of the third quarter performance as depicted from the results of IndusInd bank and Bandhan indicates that provisioning number may also decide the stock performance of the banks.

RSS
First368369370371373375376377Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR